Aligos Therapeutics, Inc. (ALGS) vs Metagenomi Therapeutics, Inc. (MGX)
- Aligos Therapeutics, Inc. ALGS 4.86 −9.83%
- Metagenomi Therapeutics, Inc. MGX 0.78 −8.24%
Aligos Therapeutics, Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Metagenomi Therapeutics, Inc. are of similar size ($33.7M and $31.9M). Aligos Therapeutics, Inc. grew revenue faster over the last twelve months: 893.0% against −59.8%. Aligos Therapeutics, Inc. has the higher net margin (−241.0% vs −689.2%) and the lower return on invested capital (−3,379.3% vs 0.00%). Across the 15 metrics below, Aligos Therapeutics, Inc. leads on 9 and Metagenomi Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ALGS | MGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (250.63%) | (741.58%) | 0.00% |
| Net margin | (241.01%) | (689.20%) | 0.00% |
| Free cash flow margin | (299.90%) | (632.67%) | 0.00% |
| Return on equity | (113.59%) | (60.61%) | (56.36%) |
| Return on assets | (75.57%) | (41.91%) | (48.04%) |
| Return on invested capital | (3,379.28%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack